WINTON GROUP Ltd Takes Position in Corteva, Inc. $CTVA

WINTON GROUP Ltd bought a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 84,345 shares of the company’s stock, valued at approximately $5,704,000.

A number of other institutional investors also recently made changes to their positions in CTVA. Chilton Capital Management LLC increased its position in Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after acquiring an additional 68,380 shares in the last quarter. TriaGen Wealth Management LLC bought a new position in shares of Corteva during the third quarter worth $4,284,000. Truist Financial Corp grew its holdings in shares of Corteva by 4.5% in the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock valued at $21,771,000 after buying an additional 13,910 shares during the period. New York State Teachers Retirement System increased its position in shares of Corteva by 4.5% in the 3rd quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock valued at $37,290,000 after buying an additional 23,548 shares in the last quarter. Finally, Alberta Investment Management Corp acquired a new stake in Corteva during the 3rd quarter worth $5,018,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.15% of the stock is owned by corporate insiders.

Corteva Trading Up 1.8%

Shares of CTVA stock opened at $78.36 on Tuesday. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90. The company has a market capitalization of $52.70 billion, a PE ratio of 49.59, a price-to-earnings-growth ratio of 2.63 and a beta of 0.72. The firm has a 50 day moving average price of $73.22 and a two-hundred day moving average price of $69.04. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same quarter last year, the company earned $0.32 earnings per share. The firm’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of research reports. Mizuho increased their target price on Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 17th. Rothschild & Co Redburn reduced their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a report on Tuesday, November 11th. BNP Paribas Exane increased their price objective on shares of Corteva from $72.00 to $74.00 in a research report on Monday. Jefferies Financial Group raised their price objective on shares of Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, March 2nd. Finally, UBS Group cut shares of Corteva from a “buy” rating to a “hold” rating in a research report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.